首页 > 最新文献

Journal of Clinical Neuroscience最新文献

英文 中文
Integrating adaptive digital health and family education: A new approach to assessing psychomotor development in malnourished children.
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-14 DOI: 10.1016/j.jocn.2025.111186
Monica Widyaswari, Ali Fakhrudin
{"title":"Integrating adaptive digital health and family education: A new approach to assessing psychomotor development in malnourished children.","authors":"Monica Widyaswari, Ali Fakhrudin","doi":"10.1016/j.jocn.2025.111186","DOIUrl":"https://doi.org/10.1016/j.jocn.2025.111186","url":null,"abstract":"","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":" ","pages":"111186"},"PeriodicalIF":1.9,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Swahili translation and cultural adaptation of the National Institutes of Health Stroke Scale
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-14 DOI: 10.1016/j.jocn.2025.111182
Peter Kuria Waweru , Samwel Maina Gatimu , Elijah Yulu , Stella Kibet , Dalphine Ndiema , Adam Mang’ombe , Sarah Shali Matuja , Innocent Kitandu Paul , Matilda K Basinda , Sospeter Berling , Gladness Xavier , Nassiuma Manakhe , Christine Tunkl , Patrick Lyden

Background

The severity of early neurologic deficits after stroke is the single most important predictor of post-stroke outcomes. Of all stroke severity scales, the National Institutes of Health Stroke Scale (NIHSS) is the most widely used. Despite being freely accessible, however, this tool remains underutilized in sub-Saharan Africa (SSA) likely due to absence of culturally adapted translations. For this reason, we translated the NIHSS to Swahili in a bid to promote its local use as an initial measure in the standardization of stroke care in the East African region. Swahili remains among the 10 most commonly spoken languages in the world, with over 200 million speakers, mostly centred in East Africa.

Methods

The NIHSS was translated into Swahili by a team of native Swahili speakers composed of two stroke physicians, two speech therapists and one nurse, and three independent translators in collaboration with the tool’s developer. Two Swahili translators performed forward translations of the original document from English to Swahili while a third independent translator performed backward translations to English, which was followed by clinician and cognitive reviews. Afterwards, reviewers from Kenya and Tanzania reviewed the tool for cross-cultural adaptation and international harmonisation. We further reconciled and generated a draft tool that was validated in Kenya and Tanzania.

Results

The NIHSS was translated into Swahili, a process that involved broad modifications of the tool including alterations of images, words and phrases to more locally familiar scenes and items. The results of validation of the Swahili version of the NIHSS in Kenya and Tanzania showed no significant differences with the original tool; with good interrater reliability in most domains.

Conclusions

The result of this process is a Swahili translation of the NIHSS that reflects the original tool. We expect the tool to help advance stroke care in Swahili-speaking regions.
{"title":"Swahili translation and cultural adaptation of the National Institutes of Health Stroke Scale","authors":"Peter Kuria Waweru ,&nbsp;Samwel Maina Gatimu ,&nbsp;Elijah Yulu ,&nbsp;Stella Kibet ,&nbsp;Dalphine Ndiema ,&nbsp;Adam Mang’ombe ,&nbsp;Sarah Shali Matuja ,&nbsp;Innocent Kitandu Paul ,&nbsp;Matilda K Basinda ,&nbsp;Sospeter Berling ,&nbsp;Gladness Xavier ,&nbsp;Nassiuma Manakhe ,&nbsp;Christine Tunkl ,&nbsp;Patrick Lyden","doi":"10.1016/j.jocn.2025.111182","DOIUrl":"10.1016/j.jocn.2025.111182","url":null,"abstract":"<div><h3>Background</h3><div>The severity of early neurologic deficits after stroke is the single most important predictor of post-stroke outcomes. Of all stroke severity scales, the National Institutes of Health Stroke Scale (NIHSS) is the most widely used. Despite being freely accessible, however, this tool remains underutilized in sub-Saharan Africa (SSA) likely due to absence of culturally adapted translations. For this reason, we translated the NIHSS to Swahili in a bid to promote its local use as an initial measure in the standardization of stroke care in the East African region. Swahili remains among the 10 most commonly spoken languages in the world, with over 200 million speakers, mostly centred in East Africa.</div></div><div><h3>Methods</h3><div>The NIHSS was translated into Swahili by a team of native Swahili speakers composed of two stroke physicians, two speech therapists and one nurse, and three independent translators in collaboration with the tool’s developer. Two Swahili translators performed forward translations of the original document from English to Swahili while a third independent translator performed backward translations to English, which was followed by clinician and cognitive reviews. Afterwards, reviewers from Kenya and Tanzania reviewed the tool for cross-cultural adaptation and international harmonisation. We further reconciled and generated a draft tool that was validated in Kenya and Tanzania.</div></div><div><h3>Results</h3><div>The NIHSS was translated into Swahili, a process that involved broad modifications of the tool including alterations of images, words and phrases to more locally familiar scenes and items. The results of validation of the Swahili version of the NIHSS in Kenya and Tanzania showed no significant differences with the original tool; with good interrater reliability in most domains.</div></div><div><h3>Conclusions</h3><div>The result of this process is a Swahili translation of the NIHSS that reflects the original tool. We expect the tool to help advance stroke care in Swahili-speaking regions.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111182"},"PeriodicalIF":1.9,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143628173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning-Based localization of the epileptogenic zone using High-Frequency oscillations from SEEG: A Real-World approach
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-13 DOI: 10.1016/j.jocn.2025.111177
Aswin Raghu , C.P. Nidhin , V.S. Sivabharathi , Pranav Rakesh Menon , Priyalakshmi Sheela , Remya Ajai , T.R. Krishnaprasad , Anand Kumar , Arjun Ramakrishnan , Siby Gopinath , Harilal Parasuram

Introduction

Localizing the epileptogenic zone (EZ) using Stereo EEG (SEEG) is often challenging through manual analysis. Even methods based on signal analysis have limitations in identifying the EZ, particularly in patients with neocortical epilepsy.

Methods

We developed machine learning (ML) methods that utilize HFO from SEEG recordings to train models to localize the EZ. We used data from 52 epilepsy patients (37 seizure free and 15 non-seizure free) who had epilepsy surgeries at our centre and were followed up for an average of 27.4 months. A total of 27 features encompassing statistical, linear, and nonlinear parameters were computed for HFOs from EZ and non-EZ brain areas. Performances of different classification algorithms were compared.

Results

In cases of mesial temporal lobe epilepsy, we achieved a cross-validation accuracy of 85.4% with the Extra-Trees classifier, 85.3% with the Random-Forest, and 82.1% with the Voting-classifier, using training data from ripples and fast ripples. For neocortical epilepsy patients, the extra trees classifier yielded an accuracy of 84.2%, while the random forest and voting classifiers attained accuracies of 84% and 80%, respectively.

Conclusion

In our approach, we employed a more realistic strategy by training the ML models at the SEEG contact level. This ensured that HFO data from a specific contact used for training the model was excluded from testing, thereby minimizing bias. This approach provides a more practical and applicable method for real-world use. Our findings indicate that the ML model-based localization of the EZ could function as an independent approach, potentially reducing the bias associated with visual analysis of SEEG.
{"title":"Machine Learning-Based localization of the epileptogenic zone using High-Frequency oscillations from SEEG: A Real-World approach","authors":"Aswin Raghu ,&nbsp;C.P. Nidhin ,&nbsp;V.S. Sivabharathi ,&nbsp;Pranav Rakesh Menon ,&nbsp;Priyalakshmi Sheela ,&nbsp;Remya Ajai ,&nbsp;T.R. Krishnaprasad ,&nbsp;Anand Kumar ,&nbsp;Arjun Ramakrishnan ,&nbsp;Siby Gopinath ,&nbsp;Harilal Parasuram","doi":"10.1016/j.jocn.2025.111177","DOIUrl":"10.1016/j.jocn.2025.111177","url":null,"abstract":"<div><h3>Introduction</h3><div>Localizing the epileptogenic zone (EZ) using Stereo EEG (SEEG) is often challenging through manual analysis. Even methods based on signal analysis have limitations in identifying the EZ, particularly in patients with neocortical epilepsy.</div></div><div><h3>Methods</h3><div>We developed machine learning (ML) methods that utilize HFO from SEEG recordings to train models to localize the EZ. We used data from 52 epilepsy patients (37 seizure free and 15 non-seizure free) who had epilepsy surgeries at our centre and were followed up for an average of 27.4 months. A total of 27 features encompassing statistical, linear, and nonlinear parameters were computed for HFOs from EZ and non-EZ brain areas. Performances of different classification algorithms were compared.</div></div><div><h3>Results</h3><div>In cases of mesial temporal lobe epilepsy, we achieved a cross-validation accuracy of 85.4% with the Extra-Trees classifier, 85.3% with the Random-Forest, and 82.1% with the Voting-classifier, using training data from ripples and fast ripples. For neocortical epilepsy patients, the extra trees classifier yielded an accuracy of 84.2%, while the random forest and voting classifiers attained accuracies of 84% and 80%, respectively.</div></div><div><h3>Conclusion</h3><div>In our approach, we employed a more realistic strategy by training the ML models at the SEEG contact level. This ensured that HFO data from a specific contact used for training the model was excluded from testing, thereby minimizing bias. This approach provides a more practical and applicable method for real-world use. Our findings indicate that the ML model-based localization of the EZ could function as an independent approach, potentially reducing the bias associated with visual analysis of SEEG.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111177"},"PeriodicalIF":1.9,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143621314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of MRI without gadolinium for follow-up of pilocytic astrocytoma in the paediatric population
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-13 DOI: 10.1016/j.jocn.2025.111173
Macfarlane Adam Ian , Soares Jewel Hannah , Maharaj Monish

Purpose

Pilocytic astrocytoma is the most common glial tumour in the paediatric population with a long-term life expectancy after surgery. Long-term radiological follow-up with magnetic resonance imaging (MRI) is necessary to detect recurrence of tumour or growth of residual tumour. Established MRI protocols typically dictate post-gadolinium sequences despite concerns around the side-effect and safety concerns of gadolinium-based contrast agents. This study aims to investigate whether omission of gadolinium-enhanced sequences for the long term follow-up MRI for paediatric patients with pilocytic astrocytoma, maintains diagnostic accuracy assessing potential recurrence or growth of residual tumour.

Methods

A retrospective review of follow-up MRI for 47 patients with histopathologically proven pilocytic astrocytoma was performed. Patients with optic pathway or suprasellar glioma were excluded from this study. All patients underwent surgery and had a minimum of 2 years of postoperative imaging for review. MRIs were chosen from most recent report of stability or at a time when growth/progression had been diagnosed. Two neuroradiologists and two paediatric neurosurgeons were randomly allocated a series of MRIs with gadolinium enhanced sequences removed, reviewers were blinded to the original report and subsequent treatment decisions. In addition, 30 paired MRI studies were randomly allocated to second review to test interobserver reliability. The reviewer responses were recorded and compared with the original report and analysed with respect to preserved diagnostic accuracy.

Results

170 MRI scans were subject to review across 66 episodes of care for 47 patients. 22.7 % of patients experienced growth of residual tumour during the period of follow-up. The sensitivity of non-enhanced MRI for detection of growth was 82 % (95 %CI 64.40–92.12) with a specificity of 97.10 % (95 % CI 90.03–99.20). Accuracy was similar for both neuroradiologists and neurosurgeons (91.49 % vs. 94 %). Interobserver reliability was calculated using Cohen’s Kappa co-efficient with a result of 0.792 showing substantial agreement. We also confirmed a statistically significant difference between gross total resection and sub-total resection and correlation with future growth (41 % vs. 0 %, n = 64, p = 0.001).

Conclusion

In paediatric patients who have undergone surgery for pilocytic astrocytoma, long term MRI follow-up without gadolinium-enhanced sequences maintains diagnostic accuracy compared with enhanced sequences. Omission of gadolinium-enhanced sequences may lead to decreased costs, duration of scans and anxiety around follow-up procedures.
{"title":"Diagnostic accuracy of MRI without gadolinium for follow-up of pilocytic astrocytoma in the paediatric population","authors":"Macfarlane Adam Ian ,&nbsp;Soares Jewel Hannah ,&nbsp;Maharaj Monish","doi":"10.1016/j.jocn.2025.111173","DOIUrl":"10.1016/j.jocn.2025.111173","url":null,"abstract":"<div><h3>Purpose</h3><div>Pilocytic astrocytoma is the most common glial tumour in the paediatric population with a long-term life expectancy after surgery. Long-term radiological follow-up with magnetic resonance imaging (MRI) is necessary to detect recurrence of tumour or growth of residual tumour. Established MRI protocols typically dictate post-gadolinium sequences despite concerns around the side-effect and safety concerns of gadolinium-based contrast agents. This study aims to investigate whether omission of gadolinium-enhanced sequences for the long term follow-up MRI for paediatric patients with pilocytic astrocytoma, maintains diagnostic accuracy assessing potential recurrence or growth of residual tumour.</div></div><div><h3>Methods</h3><div>A retrospective review of follow-up MRI for 47 patients with histopathologically proven pilocytic astrocytoma was performed. Patients with optic pathway or suprasellar glioma were excluded from this study. All patients underwent surgery and had a minimum of 2 years of postoperative imaging for review. MRIs were chosen from most recent report of stability or at a time when growth/progression had been diagnosed. Two neuroradiologists and two paediatric neurosurgeons were randomly allocated a series of MRIs with gadolinium enhanced sequences removed, reviewers were blinded to the original report and subsequent treatment decisions. In addition, 30 paired MRI studies were randomly allocated to second review to test interobserver reliability. The reviewer responses were recorded and compared with the original report and analysed with respect to preserved diagnostic accuracy.</div></div><div><h3>Results</h3><div>170 MRI scans were subject to review across 66 episodes of care for 47 patients. 22.7 % of patients experienced growth of residual tumour during the period of follow-up. The sensitivity of non-enhanced MRI for detection of growth was 82 % (95 %CI 64.40–92.12) with a specificity of 97.10 % (95 % CI 90.03–99.20). Accuracy was similar for both neuroradiologists and neurosurgeons (91.49 % vs. 94 %). Interobserver reliability was calculated using Cohen’s Kappa co-efficient with a result of 0.792 showing substantial agreement. We also confirmed a statistically significant difference between gross total resection and sub-total resection and correlation with future growth (41 % vs. 0 %, n = 64, p = 0.001).</div></div><div><h3>Conclusion</h3><div>In paediatric patients who have undergone surgery for pilocytic astrocytoma, long term MRI follow-up without gadolinium-enhanced sequences maintains diagnostic accuracy compared with enhanced sequences. Omission of gadolinium-enhanced sequences may lead to decreased costs, duration of scans and anxiety around follow-up procedures.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111173"},"PeriodicalIF":1.9,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143621313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Endonasal Excision of Giant Pituitary Neuroendocrine Tumor with Subarachnoid extension
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-13 DOI: 10.1016/j.jocn.2025.111175
Mohamed Amjad Jamaluddin , Sanal Mohan , Hiran Ramanan , R. Vijaynath , Mohammed Iqbal Jaser , Winston Markose , Palukuru Nikshith Kumar Reddy
Giant Pituitary Neuroendocrine Tumor, though challenging, if planned well can be removed endoscopically with help of significant bony drilling, angled scopes and suckers, and proper reconstruction.
巨大垂体神经内分泌瘤虽然具有挑战性,但如果计划得当,可以通过内窥镜进行切除,并辅以大量的骨钻孔、成角的探针和吸盘,以及适当的重建。
{"title":"Endoscopic Endonasal Excision of Giant Pituitary Neuroendocrine Tumor with Subarachnoid extension","authors":"Mohamed Amjad Jamaluddin ,&nbsp;Sanal Mohan ,&nbsp;Hiran Ramanan ,&nbsp;R. Vijaynath ,&nbsp;Mohammed Iqbal Jaser ,&nbsp;Winston Markose ,&nbsp;Palukuru Nikshith Kumar Reddy","doi":"10.1016/j.jocn.2025.111175","DOIUrl":"10.1016/j.jocn.2025.111175","url":null,"abstract":"<div><div>Giant Pituitary Neuroendocrine Tumor, though challenging,<!--> <!-->if planned well can be removed endoscopically<!--> <!-->with help of significant bony drilling, angled scopes and<!--> <!-->suckers, and proper reconstruction.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111175"},"PeriodicalIF":1.9,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143621179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomy of the sellar barrier: From magnetic resonance imaging to the operating room
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-12 DOI: 10.1016/j.jocn.2025.111170
Mauro Suárez , Mario Gomar-Alba , Juan F. Villalonga , Paula Alonso , Matías Baldoncini , Alvaro Campero

Background

The sellar barrier concept concerns the correlation between the components of the pituitary fossa roof and the risk of intraoperative cerebrospinal fluid (CSF) leak during pituitary tumor surgery. Our team previously classified the sellar barrier according to its thickness on contrast-enhanced T1-weighted magnetic resonance imaging (MRI) sections into three subtypes: strong, mixed or weak.
The purpose of this study is to complement the preoperative analysis of the sellar barrier with T2-weighted MRI sections to enhance our knowledge of the anatomical configuration of the sellar barrier and its correlation with the intraoperative findings.

Method

A retrospective descriptive study was performed in which medical records, neuroimaging and surgical videos of patients undergoing endoscopic endonasal surgery for pituitary tumors from January 2021 to January 2024 were reviewed. In all cases, the anatomy of the sellar barrier was evaluated by an expert neuroradiologist using pre-surgical T1-weighted MRI with gadolinium and T2-weighted images with sagittal and coronal cuts. Subsequently, the anatomical structures of the sellar barrier were compared with the direct endoscopic view observed in the operating room.

Results

A total of 108 patients were included in this study. According to the preoperative neuroimaging findings, an experienced neuroradiologist classified the type of sellar barrier as strong, mixed or weak. Additionally, the T2-weighted imaging study was systematically implemented to identify the anatomical components of the sellar barrier. We found a high correlation between the preoperative neuroimaging description and the intraoperative endoscopic view of the sellar barrier. We present eight illustrative cases herein.

Conclusions

The use of T2-weighted sequences in conjunction with gadolinium-enhanced T1-weighted images enhances the preoperative knowledge of the sellar barrier by discriminating its anatomical components with high precision. As in any neurosurgical procedure, a detailed preoperative neuroimaging study and evaluation is highly recommended in order to offer the best possible treatment to our patients affected by pituitary tumors.
{"title":"Anatomy of the sellar barrier: From magnetic resonance imaging to the operating room","authors":"Mauro Suárez ,&nbsp;Mario Gomar-Alba ,&nbsp;Juan F. Villalonga ,&nbsp;Paula Alonso ,&nbsp;Matías Baldoncini ,&nbsp;Alvaro Campero","doi":"10.1016/j.jocn.2025.111170","DOIUrl":"10.1016/j.jocn.2025.111170","url":null,"abstract":"<div><h3>Background</h3><div>The sellar barrier concept concerns the correlation between the components of the pituitary fossa roof and the risk of intraoperative cerebrospinal fluid (CSF) leak during pituitary tumor surgery. Our team previously classified the sellar barrier according to its thickness on contrast-enhanced T1-weighted magnetic resonance imaging (MRI) sections into three subtypes: strong, mixed or weak.</div><div>The purpose of this study is to complement the preoperative analysis of the sellar barrier with T2-weighted MRI sections to enhance our knowledge of the anatomical configuration of the sellar barrier and its correlation with the intraoperative findings.</div></div><div><h3>Method</h3><div>A retrospective descriptive study was performed in which medical records, neuroimaging and surgical videos of patients undergoing endoscopic endonasal surgery for pituitary tumors from January 2021 to January 2024 were reviewed. In all cases, the anatomy of the sellar barrier was evaluated by an expert neuroradiologist using pre-surgical T1-weighted MRI with gadolinium and T2-weighted images with sagittal and coronal cuts. Subsequently, the anatomical structures of the sellar barrier were compared with the direct endoscopic view observed in the operating room.</div></div><div><h3>Results</h3><div>A total of 108 patients were included in this study. According to the preoperative neuroimaging findings, an experienced neuroradiologist classified the type of sellar barrier as strong, mixed or weak. Additionally, the T2-weighted imaging study was systematically implemented to identify the anatomical components of the sellar barrier. We found a high correlation between the preoperative neuroimaging description and the intraoperative endoscopic view of the sellar barrier. We present eight illustrative cases herein.</div></div><div><h3>Conclusions</h3><div>The use of T2-weighted sequences in conjunction with gadolinium-enhanced T1-weighted images enhances the preoperative knowledge of the sellar barrier by discriminating its anatomical components with high precision. As in any neurosurgical procedure, a detailed preoperative neuroimaging study and evaluation is highly recommended in order to offer the best possible treatment to our patients affected by pituitary tumors.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111170"},"PeriodicalIF":1.9,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143609649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human-written vs. ChatGPT-generated manuscripts: Suggestions for further consideration.
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-11 DOI: 10.1016/j.jocn.2025.111172
Shigeki Matsubara
{"title":"Human-written vs. ChatGPT-generated manuscripts: Suggestions for further consideration.","authors":"Shigeki Matsubara","doi":"10.1016/j.jocn.2025.111172","DOIUrl":"https://doi.org/10.1016/j.jocn.2025.111172","url":null,"abstract":"","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":" ","pages":"111172"},"PeriodicalIF":1.9,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unplanned extubation prevention in the neuroscience ICU at a High Reliability Organization
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-10 DOI: 10.1016/j.jocn.2025.111124
Meagan Aladin , Lauren Buckley , Meghan Maloney , Pimsiri Rojanaporn , Theresa Gombar , Ariane Lewis

Background

Intubated neuroscience ICU patients are at risk for unplanned extubation (premature removal of the endotracheal tube by the patient or during patient care). The incidence of unplanned extubation is an indicator of the quality of ICU care. Unplanned extubation is a risk factor for pneumonia, increased ventilator days, the need for tracheostomy and increased ICU and hospital length-of-stay. After serial unplanned extubations, we introduced a multidisciplinary unit-based practice standard to reduce unplanned extubations as part of a quality improvement initiative in the neuroscience ICU in a large academic medical center at a High Reliability Organization in May 2021. The unit-based practice standard to guide care of intubated neuroscience ICU patients focused on communication, timely escalation of concerns, use of sedation/analgesia targeting RASS ≤ -1, soft wrist restraints (unless specified exclusion criteria met) and continuous observation for patients at high risk of agitation/restlessness. We sought to determine the impact of this initiative on the incidence of unplanned extubations.

Method

Unplanned extubations were identified via retrospective audit of prospective incident reports from our Patient Safety Incident registry pre-initiative (June 2020-May 2021) and prospective audit of incident reports post-initiative (July 2021-March 2024). Chart review facilitated collection of data on patient age, sex, diagnosis, intubation day, RASS goal, sedation/analgesia, restraints, constant observation, shift, and reintubation. The total number of intubated patients and ventilator days during these timeframes was identified retrospectively via an electronic medical record report of all patients on ventilators in the neuroscience ICU.

Results

During the pre-initiative audit period, there were 214 intubated patients (968 ventilator days). The audit identified 9 unplanned extubations (0.93/100 ventilator days; 8 males, median age 63-years-old (IQR 47–67)). There were 4 patients who were not ordered for sedation/analgesia or had a RASS goal of 0 and no patients were in nonviolent soft wrist restraints.
During the post-initiative audit period, there were 576 intubated patients (2,730 ventilator days). The audit identified 6 unplanned extubations (0.22/100 ventilator days; 6 males, median age 53-years-old (IQR 27–78)). All 6 patients had a RASS goal ≤ -1 and were in nonviolent soft wrist restraints.

Conclusion

This quality improvement initiative effectively reduced the incidence of unplanned extubations in our neuroscience ICU.
{"title":"Unplanned extubation prevention in the neuroscience ICU at a High Reliability Organization","authors":"Meagan Aladin ,&nbsp;Lauren Buckley ,&nbsp;Meghan Maloney ,&nbsp;Pimsiri Rojanaporn ,&nbsp;Theresa Gombar ,&nbsp;Ariane Lewis","doi":"10.1016/j.jocn.2025.111124","DOIUrl":"10.1016/j.jocn.2025.111124","url":null,"abstract":"<div><h3>Background</h3><div>Intubated neuroscience ICU patients are at risk for unplanned extubation (premature removal of the endotracheal tube by the patient or during patient care). The incidence of unplanned extubation is an indicator of the quality of ICU care. Unplanned extubation is a risk factor for pneumonia, increased ventilator days, the need for tracheostomy and increased ICU and hospital length-of-stay. After serial unplanned extubations, we introduced a multidisciplinary unit-based practice standard to reduce unplanned extubations as part of a quality improvement initiative in the neuroscience ICU in a large academic medical center at a High Reliability Organization in May 2021. The unit-based practice standard to guide care of intubated neuroscience ICU patients focused on communication, timely escalation of concerns, use of sedation/analgesia targeting RASS ≤ -1, soft wrist restraints (unless specified exclusion criteria met) and continuous observation for patients at high risk of agitation/restlessness. We sought to determine the impact of this initiative on the incidence of unplanned extubations.</div></div><div><h3>Method</h3><div>Unplanned extubations were identified via retrospective audit of prospective incident reports from our Patient Safety Incident registry pre-initiative (June 2020-May 2021) and prospective audit of incident reports post-initiative (July 2021-March 2024). Chart review facilitated collection of data on patient age, sex, diagnosis, intubation day, RASS goal, sedation/analgesia, restraints, constant observation, shift, and reintubation. The total number of intubated patients and ventilator days during these timeframes was identified retrospectively via an electronic medical record report of all patients on ventilators in the neuroscience ICU.</div></div><div><h3>Results</h3><div>During the pre-initiative audit period, there were 214 intubated patients (968 ventilator days). The audit identified 9 unplanned extubations (0.93/100 ventilator days; 8 males, median age 63-years-old (IQR 47–67)). There were 4 patients who were not ordered for sedation/analgesia or had a RASS goal of 0 and no patients were in nonviolent soft wrist restraints.</div><div>During the post-initiative audit period, there were 576 intubated patients (2,730 ventilator days). The audit identified 6 unplanned extubations (0.22/100 ventilator days; 6 males, median age 53-years-old (IQR 27–78)). All 6 patients had a RASS goal ≤ -1 and were in nonviolent soft wrist restraints.</div></div><div><h3>Conclusion</h3><div>This quality improvement initiative effectively reduced the incidence of unplanned extubations in our neuroscience ICU.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111124"},"PeriodicalIF":1.9,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143579414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of Integrated Patient-Reported outcome collection in outpatient cranial neurosurgical Practice: Results of qualitative interviews
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-10 DOI: 10.1016/j.jocn.2025.111171
Fatima Gauhar , Gunther W. Wong , Robert J. Dambrino , Chloe D’Agostino , Ashley Sellers , Kemberlee R. Bonnet , David G. Schlundt , Justin M. Bachmann , Reid C. Thompson , Lola B. Chambless , Peter J. Morone , Patrick D. Kelly

Objective

Patient Reported Outcome Measures (PROMs) quantify the patient’s quality of life and symptom burden. This study assesses the implementation of an automated PROM-capture system in an outpatient cranial neurosurgery clinic.

Methods

We conducted both quantitative and qualitative analyses of the implementation of a PROM tool in a single-center, dedicated brain tumor neurosurgery clinic. The primary measures were the PROMIS-10 and FACT-Br. The primary outcome of interest was PROM tool completion. For qualitative analysis, patients and providers were queried over a 6-month period to participate in a phone interview on their PROM tool experience.

Results

2,211 patients completed the PROM tool. The quantitative analysis found that white race (OR 1.42, 95% CI 1.21 – 1.68), being of non-Hispanic ethnicity (OR 1.20, 95% CI 1.06 – 1.37), or having private insurance (OR 1.28, 95% CI 1.08 – 1.53) were all associated with higher odds of PROM tool completion. Having an inactive patient portal – My Health At Vanderbilt (MHAV [OR 0.62, 95% CI 0.42 – 0.90]), or appointment providers were associated with decreased odds of PROM tool completion. In-person visits for new patients or for follow-up care were less likely to complete PROM tools as compared to telehealth. Fifteen patients and two providers participated in the phone interview, and the demographics of this group matched the overall cohort. Both patients and providers felt the PROM tool was pertinent, beneficial to patient care, and focused communication between the patient and provider.

Conclusions

This implementation study identified several barriers to developing an automated PROM-collection system in an outpatient cranial neurosurgery practice. These findings have been used to refine this system at our institution and may inform similar implementations elsewhere.
{"title":"Implementation of Integrated Patient-Reported outcome collection in outpatient cranial neurosurgical Practice: Results of qualitative interviews","authors":"Fatima Gauhar ,&nbsp;Gunther W. Wong ,&nbsp;Robert J. Dambrino ,&nbsp;Chloe D’Agostino ,&nbsp;Ashley Sellers ,&nbsp;Kemberlee R. Bonnet ,&nbsp;David G. Schlundt ,&nbsp;Justin M. Bachmann ,&nbsp;Reid C. Thompson ,&nbsp;Lola B. Chambless ,&nbsp;Peter J. Morone ,&nbsp;Patrick D. Kelly","doi":"10.1016/j.jocn.2025.111171","DOIUrl":"10.1016/j.jocn.2025.111171","url":null,"abstract":"<div><h3>Objective</h3><div>Patient Reported Outcome Measures (PROMs) quantify the patient’s quality of life and symptom burden. This study assesses the implementation of an automated PROM-capture system in an outpatient cranial neurosurgery clinic.</div></div><div><h3>Methods</h3><div>We conducted both quantitative and qualitative analyses of the implementation of a PROM tool in a single-center, dedicated brain tumor neurosurgery clinic. The primary measures were the PROMIS-10 and FACT-Br. The primary outcome of interest was PROM tool completion. For qualitative analysis, patients and providers were queried over a 6-month period to participate in a phone interview on their PROM tool experience.</div></div><div><h3>Results</h3><div>2,211 patients completed the PROM tool. The quantitative analysis found that white race (OR 1.42, 95% CI 1.21 – 1.68), being of non-Hispanic ethnicity (OR 1.20, 95% CI 1.06 – 1.37), or having private insurance (OR 1.28, 95% CI 1.08 – 1.53) were all associated with higher odds of PROM tool completion. Having an inactive patient portal – My Health At Vanderbilt (MHAV [OR 0.62, 95% CI 0.42 – 0.90]), or appointment providers were associated with decreased odds of PROM tool completion. In-person visits for new patients or for follow-up care were less likely to complete PROM tools as compared to telehealth. Fifteen patients and two providers participated in the phone interview, and the demographics of this group matched the overall cohort. Both patients and providers felt the PROM tool was pertinent, beneficial to patient care, and focused communication between the patient and provider.</div></div><div><h3>Conclusions</h3><div>This implementation study identified several barriers to developing an automated PROM-collection system in an outpatient cranial neurosurgery practice. These findings have been used to refine this system at our institution and may inform similar implementations elsewhere.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111171"},"PeriodicalIF":1.9,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143579445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timely access to neurosurgical public care in Peru: A geospatial analysis
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-03-09 DOI: 10.1016/j.jocn.2025.111143
Jhon E. Bocanegra-Becerra

Introduction

Understanding geographic access to neurosurgical care is key to ensuring timely treatment, particularly in countries with challenging topography like Peru. This investigation sought to estimate Peru’s population distribution within critical time intervals and proximity to the nearest neurosurgical facility in the Ministry of Health network.

Methods

A geospatial analysis was conducted to assess the distribution of Peru’s population across its 25 regions within six travel time areas (1 h, 2 h, 4 h, 6 h, 1 day, and 5 days) to the nearest neurosurgical facility.

Results

Twenty-five facilities were identified across Peru, of which 92 % pertained to tertiary or higher-level facilities and were included in the analysis. Peru’s population was estimated at 32,625,937 people. Lima concentrates 52.17 % of neurosurgical facilities. Nearly 13,819,251 people (42.36 %) could lack neurosurgical access within 4 h of travel. About 302,733 people (31.3 %) living in the region of Loreto could access neurosurgical treatment in up to 5 days of travel.

Conclusion

Geographic access to neurosurgical care in Peru is heterogeneous. Major hospital settings remain centralized in the regions of Lima and Callao. Virtually 42.36 % of the Peruvian population could not access timely neurosurgical care within 4 h of travel. Notably, roughly one-third of the population in the Amazon area of Loreto could access a neurosurgical setting in up to 5 days of travel. These findings can incentivize further assessment of underserved regions, prioritization of infrastructure development, and synergistic policy interventions from governmental and non-governmental organizations.
{"title":"Timely access to neurosurgical public care in Peru: A geospatial analysis","authors":"Jhon E. Bocanegra-Becerra","doi":"10.1016/j.jocn.2025.111143","DOIUrl":"10.1016/j.jocn.2025.111143","url":null,"abstract":"<div><h3>Introduction</h3><div>Understanding geographic access to neurosurgical care is key to ensuring timely treatment, particularly in countries with challenging topography like Peru. This investigation sought to estimate Peru’s population distribution within critical time intervals and proximity to the nearest neurosurgical facility in the Ministry of Health network.</div></div><div><h3>Methods</h3><div>A geospatial analysis was conducted to assess the distribution of Peru’s population across its 25 regions within six travel time areas (1 h, 2 h, 4 h, 6 h, 1 day, and 5 days) to the nearest neurosurgical facility.</div></div><div><h3>Results</h3><div>Twenty-five facilities were identified across Peru, of which 92 % pertained to tertiary or higher-level facilities and were included in the analysis. Peru’s population was estimated at 32,625,937 people. Lima concentrates 52.17 % of neurosurgical facilities. Nearly 13,819,251 people (42.36 %) could lack neurosurgical access within 4 h of travel. About 302,733 people (31.3 %) living in the region of Loreto could access neurosurgical treatment in up to 5 days of travel.</div></div><div><h3>Conclusion</h3><div>Geographic access to neurosurgical care in Peru is heterogeneous. Major hospital settings remain centralized in the regions of Lima and Callao. Virtually 42.36 % of the Peruvian population could not access timely neurosurgical care within 4 h of travel. Notably, roughly one-third of the population in the Amazon area of Loreto could access a neurosurgical setting in up to 5 days of travel. These findings can incentivize further assessment of underserved regions, prioritization of infrastructure development, and synergistic policy interventions from governmental and non-governmental organizations.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"135 ","pages":"Article 111143"},"PeriodicalIF":1.9,"publicationDate":"2025-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143579413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Neuroscience
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1